The goal of this clinical trial is to test an mHealth intervention for cervical cancer prevention in under-screened women ages 25-64 on the Caribbean Coast of Nicaragua. The mHealth intervention combines a patient-centered mobile app, a provider portal, and connectivity to the National Breast and Cervical Cancer Surveillance System (SIVIPCAN). The mHealth intervention will be combined with HPV primary screening for cervical cancer. The main questions it aims to answer are, when integrated into an HPV-based screening program:
Is the mHealth intervention acceptable? Is the mHealth intervention feasible?
Researchers will compare the intervention group (mHealth intervention) to the control group (standard care).
Participants will:
Receive HPV-based cervical screening. Intervention group: Through the patient-centered app, participants will receive "results ready" notification and navigation to the clinic for follow-up.
Control group: Participants will receive "results ready" notification and navigation to the clinic for follow-up through existing communication channels.